| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $3.48 | $2.88 | $2.64 | $1.70 | $0.44 |
| EPS (Diluted) | $3.44 | $2.86 | $2.61 | $1.68 | $0.44 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $8.3B | $8.0B | $7.8B | $7.1B | $6.0B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.3B | $0.0B |
| Total Liabilities | $7.5B | $7.4B | $7.3B | $6.5B | $5.4B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.6B | $0.5B | $0.6B | $0.5B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-1.2B | $-0.9B | $-0.8B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $0.0B | $0.8B | $1.1B | $0.6B |